Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions

v3.8.0.1
Related Party Transactions
3 Months Ended
Mar. 31, 2018
Related Party Transactions [Abstract]  
Related Party Note
17. Related Party Transactions
 
Other Related Parties
 
The Company’s Chairman, President and Chief Executive Officer, individually and through certain trusts over which he has voting and dispositive control, beneficially owned approximately 13.7% of the Company’s issued and outstanding Common Stock as of March 31, 2018. The Company’s Executive Vice Chairman, Strategic Development owns approximately 16.0% of the Company’s issued and outstanding Common Stock at March 31, 2018.
 
Shared Services Agreement with TGTX
 
TGTX and the Company entered into an arrangement to share the cost of certain research and development employees. The Company’s Executive Vice Chairman, Strategic Development, is Executive Chairman and Interim Chief Executive Officer of TGTX. Under the terms of the Agreement, TGTX will reimburse the Company for the salary and benefit costs associated with these employees based upon actual hours worked on TGTX related projects. For the three months ended March 31, 2018 and 2017, the Company invoiced TGTX $0.3 million and $0.2 million, respectively. At March 31, 2018, the amount receivable from TGTX related to this arrangement approximated $0.3 million.
 
Desk Space Agreements with TGTX and OPPM
 
In connection with the Company’s Desk Space Agreements with TGTX and Opus Point Partners Management, LLC (“OPPM”), as of March 31, 2018, the Company had paid $0.6 million in rent under the Desk Space Agreements, and invoiced OPPM and TGTX approximately $42,000 and $0.3 million, respectively, for their prorated share of the rent base. In addition, for the three months ended March 31, 2018, the Company had incurred approximately $32,000 in connection with the build out of the space and recorded a receivable of $14,000 due from TGTX and $3,000 due from OPPM. At March 31, 2018, the amount due from TGTX approximated $137,000 and the amount due from OPPM approximated $61,000.
 
Opus Credit Facility
 
On March 12, 2018, the Company and OPHIF amended and restated the Opus Credit Facility (the “A&R Opus Credit Facility”). The A&R Opus Credit Facility extends the maturity date of the notes issued under the Opus Credit Facility from September 14, 2018 by one year to September 14, 2019. The A&R Opus Credit Facility also permits the Company to make portions of interest and principal repayments in the form of shares of the Company’s common stock and/or in common stock of the Company’s publicly-traded subsidiaries, subject to certain conditions. Fortress retains the ability to prepay the Notes at any time without penalty. The notes payable under the A&R Opus Credit Facility continue to bear interest at 12% per annum (see Note 11). For the three months ended March 31, 2018 and 2017, we paid $0.3 million and $0.2 million, respectively.
 
Checkpoint Public Offering of Common Stock
 
NSC, a subsidiary of National (of which the Company owns 56.6% and Michael Weiss serves as Chairman of the Board of Directors), served as the Sole Book Running Manager in connection with Checkpoint’s 2018 Equity Offering, which closed on March 12, 2018. As the Sole Book Running Manager, NSC received a fee of approximately $1.8 million, or 8% on the gross proceeds raised of $23.0 million.  The fees were eliminated in consolidation.
 
Mustang Option on Collaboration Agreement with TGTX
 
On February 2, 2018 Mustang entered into an Option Agreement the (“TGTX Mustang Option”) with TG Therapeutics, Inc. (“TGTX”), a related party, whereby TGTX was granted the option to enter into a global collaboration on the joint development and commercialization of product candidates pertaining to Mustang’s CD20 license agreement with the Fred Hutchinson Cancer Research Center. In consideration of the TGTX Mustang Option, TGTX paid an option fee of $50,000, which was recorded by Mustang as Collaboration Revenue Related Party in the Condensed Consolidated Statement of Operations. The Option expires 180 days after the effective date and can be extended for three months upon mutual written consent. Mr. Weiss, our Executive Vice Chairman, Strategic Development, serves as the Chief Executive Officer of TGTX.
  
2018 Venture Notes
 
For the period ended March 31, 2018, the Company raised approximately $21.7 million in promissory notes. National Securities Corporation (“NSC”), a wholly owned subsidiary of National, and a related party as a result of the Company’s ownership of National, acted as the sole placement agent for the 2018 Venture Notes. The Company paid NSC a fee of $1.7 million during the three months ended March 31, 2018, in connection with the 2018 Venture Notes. At March 31, 2018, the fee, which was recorded as debt discount on the Company’s Condensed Consolidated Balance Sheet and will be amortized over the life of the 2018 Venture Notes, was eliminated in consolidation.
 
Founders Agreements
 
The Company has entered into Founders Agreements and, in some cases, Exchange Agreements with certain of its subsidiaries as described in the Company’s Form 10-K for the year ended December 31, 2017, filed with the SEC on March 16, 2018. The following table summarizes, by subsidiary, the effective date of the Founders Agreements and PIK dividend or equity fee payable to the Company in accordance with the terms of the Founders Agreements, Exchange Agreements and the subsidiaries’ certificates of incorporation.
 
Fortress Company
 
Effective Date  (1)
 
PIK Dividend as
a % of fully
diluted
outstanding
capitalization
 
Class of Stock
Issued
 
Helocyte
 
March 20, 2015
 
 
2.5
%
Common Stock
 
Avenue
 
February 17, 2015
 
 
2.5
%
Common Stock
 
Mustang
 
March 13, 2015
 
 
2.5
%
Common Stock
 
Checkpoint
 
March 17, 2015
 
 
0.0
% (2)
Common Stock
 
Cellvation
 
October 31, 2016
 
 
2.5
%
Common Stock
 
Caelum
 
January 1, 2017
 
 
2.5
%
Common Stock
 
Cyprium
 
March 13, 2017
 
 
2.5
%
Common Stock
 
Aevitas
 
July 28, 2017
 
 
2.5
%
Common Stock
 
Tamid
 
November 30, 2017 (3)
 
 
2.5
%
Common Stock
 
 
(1) - Represents the effective date of each subsidiary’s Founders Agreement. Each PIK dividend and equity fee is payable on the annual anniversary of the effective date of the original Founders Agreement.
 
(2) - Instead of a PIK dividend, Checkpoint pays the Company an annual equity fee in shares of Checkpoint’s common stock equal to 2.5% of Checkpoint’s fully diluted outstanding capitalization.
 
(3) - Represents the Trigger Date.
 
Management Services Agreements
 
The Company has entered in Management Services Agreements (the “MSAs”) with certain of its subsidiaries as described in the Company’s Form 10-K for the year ended December 31, 2017, filed with the SEC on March 16, 2018. The following table summarizes, by subsidiary, the effective date of the MSA and the annual consulting fee payable by the subsidiary to the Company in quarterly installments:
 
Fortress Company
 
Effective Date
 
Annual MSA Fee
(Income)/Expense
 
Helocyte
 
March 20, 2015
 
$
500
 
Avenue (1)
 
February 17, 2015
 
 
500
 
Mustang
 
March 13, 2015
 
 
500
 
Checkpoint
 
March 17, 2015
 
 
500
 
Cellvation
 
October 31, 2016
 
 
500
 
Caelum
 
January 1, 2017
 
 
500
 
Cyprium
 
March 13, 2017
 
 
500
 
Aevitas
 
July 28, 2017
 
 
500
 
Tamid
 
November 30, 2017
 
 
500
 
Fortress
 
 
 
 
(4,500)
 
Consolidated (Income)/Expense
 
 
 
$
-
 
 
Chord Advisors, LLC
 
In May 2015, the Company entered into a full-service consulting agreement with Chord Advisors, LLC (“Chord”) to provide advisory accounting services. Under the terms of the agreement, the Company pays Chord $10,000 per month to provide technical accounting and financial reporting support. Either party upon 30-days written notice can terminate the agreement. Mr. Horin, Managing Partner of Chord, serves as Interim Chief Financial Officer to Caelum  and Helocyte. Pursuant to the agreements with Caelum and Helocyte, Chord provides back office accounting support and accounting policy and financial reporting services, including the services of Mr. Horin. Chord receives up to $5,000 per month from Caelum and Helocyte. For the three months ended March 31, 2018 and 2017, Caelum and Helocyte together incurred approximately $11,000 and $13,000, respectively, in fees.
 
National
 
As of March 31, 2018, the Company owns approximately 56.6% of National. The Company’s Executive Vice Chairman, Strategic Development is the Chairman of the Board of National.
 
Additionally, the Company’s Chairman, President and Chief Executive Officer and the Company’s Executive Vice Chairman, Strategic Development are both Co-Portfolio Managers and Partners of OPPM which owns approximately 4.6% of National. In the normal course, National provides the Company and the Company’s subsidiaries with placement agent services in connection with third party raises. These fees are eliminated in consolidation.